DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,467 | +8.7% | 175,201 | +5.1% | 0.29% | +7.1% |
| Q2 2023 | $39,998 | -0.3% | 166,659 | +4.7% | 0.27% | -0.4% |
| Q1 2023 | $40,118 | -12.2% | 159,174 | -7.6% | 0.27% | -19.2% |
| Q4 2022 | $45,707 | -99.9% | 172,208 | -12.6% | 0.33% | -9.5% |
| Q3 2022 | $50,877,000 | +1.7% | 196,977 | -0.2% | 0.37% | +9.5% |
| Q2 2022 | $50,040,000 | -28.4% | 197,381 | -17.1% | 0.34% | -5.9% |
| Q1 2022 | $69,846,000 | -7.0% | 238,113 | +4.3% | 0.36% | +6.2% |
| Q4 2021 | $75,130,000 | +19.2% | 228,353 | +10.3% | 0.34% | -0.9% |
| Q3 2021 | $63,048,000 | +48.0% | 207,094 | +30.5% | 0.34% | +44.7% |
| Q2 2021 | $42,593,000 | -32.2% | 158,716 | -43.1% | 0.24% | -32.9% |
| Q1 2021 | $62,823,000 | +16.1% | 279,112 | +14.6% | 0.35% | +7.4% |
| Q4 2020 | $54,111,000 | +15.0% | 243,590 | +11.4% | 0.33% | +7.2% |
| Q3 2020 | $47,064,000 | +279.6% | 218,567 | +211.7% | 0.30% | +201.0% |
| Q2 2020 | $12,398,000 | +103.2% | 70,111 | +59.0% | 0.10% | +55.4% |
| Q1 2020 | $6,102,000 | -36.4% | 44,087 | -29.5% | 0.06% | -13.3% |
| Q4 2019 | $9,594,000 | -18.8% | 62,511 | -23.6% | 0.08% | -27.2% |
| Q3 2019 | $11,821,000 | -80.1% | 81,847 | -80.3% | 0.10% | -79.1% |
| Q2 2019 | $59,492,000 | +4.6% | 416,263 | -3.4% | 0.49% | +1.6% |
| Q1 2019 | $56,870,000 | +35.6% | 430,769 | +5.9% | 0.49% | +24.0% |
| Q4 2018 | $41,929,000 | -9.5% | 406,603 | -4.7% | 0.39% | +21.0% |
| Q3 2018 | $46,345,000 | -8.0% | 426,514 | -16.4% | 0.32% | +1.2% |
| Q2 2018 | $50,355,000 | +10.8% | 510,281 | +10.0% | 0.32% | +4.6% |
| Q1 2018 | $45,439,000 | +11.4% | 464,085 | +5.6% | 0.31% | +12.5% |
| Q4 2017 | $40,776,000 | +20.4% | 439,302 | +11.2% | 0.27% | +30.8% |
| Q3 2017 | $33,873,000 | +147.2% | 394,880 | +143.2% | 0.21% | +121.3% |
| Q2 2017 | $13,702,000 | +1.2% | 162,370 | +2.5% | 0.09% | -3.1% |
| Q1 2017 | $13,543,000 | +37.4% | 158,341 | +25.0% | 0.10% | +36.6% |
| Q4 2016 | $9,860,000 | -12.6% | 126,675 | -12.0% | 0.07% | -10.1% |
| Q3 2016 | $11,281,000 | -83.8% | 143,903 | -79.1% | 0.08% | -83.3% |
| Q2 2016 | $69,543,000 | +6.7% | 688,542 | +0.2% | 0.47% | +7.7% |
| Q1 2016 | $65,203,000 | +40.4% | 687,360 | +37.5% | 0.44% | +31.0% |
| Q4 2015 | $46,446,000 | +0.8% | 500,069 | -7.5% | 0.34% | -7.4% |
| Q3 2015 | $46,087,000 | -0.2% | 540,866 | +0.3% | 0.36% | +4.3% |
| Q2 2015 | $46,173,000 | +39.3% | 539,463 | +38.2% | 0.35% | +35.4% |
| Q1 2015 | $33,137,000 | -1.2% | 390,302 | -0.2% | 0.26% | -2.3% |
| Q4 2014 | $33,536,000 | +29.5% | 391,271 | +14.8% | 0.26% | +22.3% |
| Q3 2014 | $25,898,000 | -7.4% | 340,849 | -4.0% | 0.22% | -6.9% |
| Q2 2014 | $27,960,000 | +5.7% | 355,133 | +0.7% | 0.23% | -3.8% |
| Q1 2014 | $26,461,000 | -8.2% | 352,811 | -5.5% | 0.24% | -4.4% |
| Q4 2013 | $28,824,000 | +12.2% | 373,374 | +0.8% | 0.25% | +11.6% |
| Q3 2013 | $25,683,000 | -2.2% | 370,495 | -10.7% | 0.22% | -5.9% |
| Q2 2013 | $26,256,000 | – | 414,779 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |